Arboso, Victoriano .
HRN: 27-29-78 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/12/2025
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
06/12/2025
06/18/2025
IVT
500mg
OD
CAP HR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes